David Turkaly
Stock Analyst at Citizens JMP
(0.26)
# 4,446
Out of 4,651 analysts
439
Total ratings
39.4%
Success rate
-3.7%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintained: Buy | $440 → $400 | $339.21 | +17.92% | 22 | Aug 3, 2026 | |
| AXGN Axogen | Maintained: Buy | $50 → $55 | $48.73 | +12.87% | 31 | Jul 30, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $85 → $115 | $100.95 | +13.92% | 21 | May 8, 2026 | |
| MDXG MiMedx Group | Maintained: Buy | $7 → $6 | $4.27 | +40.52% | 3 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Buy | $125 → $105 | $100.65 | +4.32% | 29 | Apr 29, 2026 | |
| TELA TELA Bio | Maintained: Buy | $5 → $3 | $0.6443 | +365.62% | 23 | Mar 27, 2026 | |
| APYX Apyx Medical | Upgraded: Buy | $8 | $3.03 | +164.03% | 34 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Maintained: Buy | $35 → $25 | $24.80 | +0.81% | 37 | Oct 10, 2025 | |
| GMED Globus Medical | Reiterated: Hold | n/a | $85.90 | - | 24 | Aug 20, 2025 | |
| IART Integra LifeSciences Holdings | Reiterated: Buy | $25 | $18.34 | n/a | 31 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.30 | n/a | 23 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $90.80 | n/a | 33 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $280 | $233.28 | n/a | 40 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $55 | $26.06 | n/a | 4 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $18.93 | n/a | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $137.17 | n/a | 24 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.34 | n/a | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.97 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $72.95 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.12 | n/a | 2 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $9.45 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.84 | n/a | 1 | Jun 25, 2009 |
Stryker
Aug 3, 2026
Maintained: Buy
Price Target: $440 → $400
Current: $339.21
Upside: +17.92%
Axogen
Jul 30, 2026
Maintained: Buy
Price Target: $50 → $55
Current: $48.73
Upside: +12.87%
Lantheus Holdings
May 8, 2026
Maintained: Buy
Price Target: $85 → $115
Current: $100.95
Upside: +13.92%
MiMedx Group
Apr 30, 2026
Maintained: Buy
Price Target: $7 → $6
Current: $4.27
Upside: +40.52%
Zimmer Biomet Holdings
Apr 29, 2026
Maintained: Buy
Price Target: $125 → $105
Current: $100.65
Upside: +4.32%
TELA Bio
Mar 27, 2026
Maintained: Buy
Price Target: $5 → $3
Current: $0.6443
Upside: +365.62%
Apyx Medical
Nov 12, 2025
Upgraded: Buy
Price Target: $8
Current: $3.03
Upside: +164.03%
OrthoPediatrics
Oct 10, 2025
Maintained: Buy
Price Target: $35 → $25
Current: $24.80
Upside: +0.81%
Globus Medical
Aug 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $85.90
Upside: -
Integra LifeSciences Holdings
Aug 1, 2025
Reiterated: Buy
Price Target: $25
Current: $18.34
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: $7
Current: $3.30
Upside: n/a
May 20, 2025
Reiterated: Buy
Price Target: $100
Current: $90.80
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $265 → $280
Current: $233.28
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $62 → $55
Current: $26.06
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $32
Current: $18.93
Upside: n/a
Apr 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $137.17
Upside: n/a
Mar 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.34
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $9.97
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $72.95
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $10.12
Upside: n/a
Jun 3, 2016
Reiterated: Buy
Price Target: $17
Current: $9.45
Upside: n/a
Jun 25, 2009
Downgraded: Hold
Price Target: n/a
Current: $3.84
Upside: n/a